|Medicare Evidence Development & Coverage Advisory Committee (MEDCAC)(formerly know as MCAC)
The MEDCAC (formerly know as MCAC) advises CMS on whether specific medical items and services are reasonable and necessary under Medicare law. They perform this task via a careful review and discussion of specific clinical and scientific issues in an open and public forum. The MEDCAC (formerly know as MCAC) is advisory in nature, with the final decision on all issues resting with CMS. Accordingly, the advice rendered by the MEDCAC (formerly know as MCAC) is most useful when it results from a process of full scientific inquiry and thoughtful discussion, in an open forum, with careful framing of recommendations and clear identification of the basis of those recommendations.
The MEDCAC (formerly know as MCAC) is used to supplement CMS's internal expertise and to ensure an unbiased and contemporary consideration of "state of the art" technology and science. Accordingly, MEDCAC (formerly know as MCAC) members are valued for their background, education, and expertise in a wide variety of scientific, clinical, and other related fields. In composing the MEDCAC (formerly know as MCAC), CMS was diligent in pursuing ethnic, gender, geographic, and other diverse views, and to carefully screen each member to determine potential conflicts of interest.